Literature DB >> 21360544

Microarray hybridization for assessment of the genetic stability of chimeric West Nile/dengue 4 virus.

Majid Laassri1, Bella Bidzhieva, James Speicher, Alexander G Pletnev, Konstantin Chumakov.   

Abstract

Genetic stability is an important characteristic of live viral vaccines because an accumulation of mutants can cause reversion to a virulent phenotype as well as a loss of immunogenic properties. This study was aimed at evaluating the genetic stability of a live attenuated West Nile (WN) virus vaccine candidate that was generated by replacing the pre-membrane and envelope protein genes of dengue 4 virus with those from WN. Chimeric virus was serially propagated in Vero, SH-SY5Y human neuroblastoma and HeLa cells and screened for point mutations using hybridization with microarrays of overlapping oligonucleotide probes covering the entire genome. The analysis revealed several spontaneous mutations that led to amino acid changes, most of which were located in the envelope (E) and non-structural NS4A, NS4B, and NS5 proteins. Viruses passaged in Vero and SH-SY5Y cells shared two common mutations: G(2337) C (Met(457) Ile) in the E gene and A(6751) G (Lys(125) Arg) in the NS4A gene. Quantitative assessment of the contents of these mutants in viral stocks indicated that they accumulated independently with different kinetics during propagation in cell cultures. Mutant viruses grew better in Vero cells compared to the parental virus, suggesting that they have a higher fitness. When tested in newborn mice, the cell culture-passaged viruses did not exhibit increased neurovirulence. The approach described in this article could be useful for monitoring the molecular consistency and quality control of vaccine strains.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360544      PMCID: PMC3410669          DOI: 10.1002/jmv.22033

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  29 in total

1.  Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.

Authors:  S L Allison; J Schalich; K Stiasny; C W Mandl; F X Heinz
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing.

Authors:  Konstantin V Pugachev; Simeon W Ocran; Farshad Guirakhoo; Dean Furby; Thomas P Monath
Journal:  Vaccine       Date:  2002-01-15       Impact factor: 3.641

3.  High fidelity of yellow fever virus RNA polymerase.

Authors:  Konstantin V Pugachev; Farshad Guirakhoo; Simeon W Ocran; Fred Mitchell; Megan Parsons; Caroline Penal; Soheila Girakhoo; Svetlana O Pougatcheva; Juan Arroyo; Dennis W Trent; Thomas P Monath
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

4.  Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine.

Authors:  K M Chumakov; L B Powers; K E Noonan; I B Roninson; I S Levenbook
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

5.  UNIOVULAR TWINS IN MICE.

Authors:  S C Reed
Journal:  Science       Date:  1938-07-01       Impact factor: 47.728

6.  Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

Authors:  A P Durbin; R A Karron; W Sun; D W Vaughn; M J Reynolds; J R Perreault; B Thumar; R Men; C J Lai; W R Elkins; R M Chanock; B R Murphy; S S Whitehead
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

7.  West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy.

Authors:  Alexander G Pletnev; Robert Putnak; Jim Speicher; Eric J Wagar; David W Vaughn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

8.  Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.

Authors:  T P Monath; K Soike; I Levenbook; Z X Zhang; J Arroyo; S Delagrave; G Myers; A D Barrett; R E Shope; M Ratterree; T J Chambers; F Guirakhoo
Journal:  Vaccine       Date:  1999-04-09       Impact factor: 3.641

9.  Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.

Authors:  F Guirakhoo; K Pugachev; Z Zhang; G Myers; I Levenbook; K Draper; J Lang; S Ocran; F Mitchell; M Parsons; N Brown; S Brandler; C Fournier; B Barrere; F Rizvi; A Travassos; R Nichols; D Trent; T Monath
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures.

Authors:  Shelly J Robertson; Dana N Mitzel; R Travis Taylor; Sonja M Best; Marshall E Bloom
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more
  7 in total

Review 1.  Current trends in West Nile virus vaccine development.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2014-04-01       Impact factor: 5.217

2.  Differentiated Human SH-SY5Y Cells Provide a Reductionist Model of Herpes Simplex Virus 1 Neurotropism.

Authors:  Mackenzie M Shipley; Colleen A Mangold; Chad V Kuny; Moriah L Szpara
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

3.  The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers.

Authors:  Anna P Durbin; Peter F Wright; Amber Cox; Wangeci Kagucia; Daniel Elwood; Susan Henderson; Kimberli Wanionek; Jim Speicher; Stephen S Whitehead; Alexander G Pletnev
Journal:  Vaccine       Date:  2013-08-19       Impact factor: 3.641

4.  Infectious clones of novel lineage 1 and lineage 2 West Nile virus strains WNV-TX02 and WNV-Madagascar.

Authors:  Mehul S Suthar; Margaret M Brassil; Gabriele Blahnik; Michael Gale
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

5.  Genome-wide host responses against infectious laryngotracheitis virus vaccine infection in chicken embryo lung cells.

Authors:  Jeongyoon Lee; Walter G Bottje; Byung-Whi Kong
Journal:  BMC Genomics       Date:  2012-04-24       Impact factor: 3.969

6.  Remodeling of the Actin Network Associated with the Non-Structural Protein 1 (NS1) of West Nile Virus and Formation of NS1-Containing Tunneling Nanotubes.

Authors:  Wilhelm Furnon; Pascal Fender; Marie-Pierre Confort; Sophie Desloire; Sawitree Nangola; Kuntida Kitidee; Caroline Leroux; Maxime Ratinier; Frédérick Arnaud; Sylvie Lecollinet; Pierre Boulanger; Saw-See Hong
Journal:  Viruses       Date:  2019-09-27       Impact factor: 5.048

7.  The Implications of Fragmented Genomic DNA Size Range on the Hybridization Efficiency in NanoGene Assay.

Authors:  Xiaofang Wang; Beelee Chua; Ahjeong Son
Journal:  Sensors (Basel)       Date:  2018-08-13       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.